Study Comparing Minimally-Invasive Hybrid Ablation and Standard Catheter Ablation
for Persistent Atrial Fibrillation with Heart Failure
Led by St. George's Hospital, London · Updated on 2025-11-28
120
Participants Needed
7
Research Sites
74 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of a staged hybrid ablation procedure compared to the standard catheter ablation in patients with non-paroxysmal atrial fibrillation AF and heart failure. This randomized controlled trial aims to determine which approach better prevents persistent atrial arrhythmia over a follow-up period extending to 24 months after treatment.
Participants will be randomly assigned to one of two treatment groups. One group will undergo a staged convergent hybrid ablation, consisting of a minimally invasive surgical epicardial ablation with optional left atrial appendage exclusion followed by an endocardial catheter ablation. The other group will receive the standard percutaneous endocardial catheter ablation alone. The trial compares these two device-based procedures to assess their impact on heart rhythm and heart function.
During the study, participants will be closely monitored for heart rhythm changes, heart chamber remodeling, and quality of life using various assessments before treatment and at 12 and 24 months afterward. The main outcome measured is freedom from persistent atrial arrhythmia after a single procedure without certain medications. Safety is also tracked within 30 days and beyond. Overall, the trial will last at least two years for each participant, including follow-up evaluations at multiple time points.
CONDITIONS
Brief Title
Hybrid Ablation of Atrial Fibrillation in Heart Failure
Research Team
R
Riyaz A Kaba
O
Omar Ahmed
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Persistent or long-standing persistent atrial fibrillation
Moderately or more dilated left atrium
Suitable for either the staged hybrid ablation or standard catheter ablation procedure
Left ventricular ejection fraction less than 50%
You will not qualify if you...
Not optimized medically or lifestyle-wise for atrial fibrillation or heart failure
Unable to provide written consent
Previous open-heart surgery
Active infection, esophageal ulcer, stricture, or varices
Prior catheter ablation of atrial fibrillation
Contraindication to anticoagulation or active left atrial thrombus despite treatment
Severe valvular heart disease
Unstable coronary artery disease
Uncontrolled ventricular arrhythmia
Heart attack or stroke within the last 90 days
Pregnant, breastfeeding, or planning pregnancy within six months
Severe other health condition or implanted device preventing trial procedures
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to 24 months with assessment after a 3-month blanking period
Participants undergo either the staged Convergent hybrid ablation procedure involving a minimally-invasive surgical epicardial ablation followed by endocardial catheter ablation, or standard endocardial catheter ablation for atrial fibrillation and heart failure.
1 to 2 procedure visits depending on treatment assignment and follow-up visits at 12 and 24 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Phase 2 Study of 18F-mFBG PET Imaging
for Heart Failure Patients with Ischemic Cardiomyopathy
and Implantable Cardioverter-Defibrillators
Post-Discharge Counseling and Phone Follow-Up to Reduce Heart Failure Readmissions at Komfo Anokye Teaching Hospital
Myocardial Energetic Profiling Using 31P Magnetic Resonance Spectroscopy
and Prognostic Assessment Across Heart Failure and Cardiomyopathy Types
Using 320-Detector CT to Measure Heart Tissue Fibrosis in Adults with Atrial Fibrillation
Before Catheter Ablation Treatment
3D Imaging Study of Right Heart Function During Mechanical Pump Placement for Heart Failure
Evaluating Cardiac Fibrosis in Heart Failure Using 68Ga-FAPI PETCT Compared to MRI
A Pilot Study in Patients with HFrEF and HFpEF
Study of Vascular Function and Exercise Effects in Aging and Cardiovascular Diseases Including COPD and Pulmonary Hypertension
A Phase I Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Effects of Oral Doses of HRS-5765 in Healthy Adults Aged 18 to 65
Phase I Study Evaluating Safety and Pharmacokinetics of Single and Multiple Oral Doses of HRS-7156 in Healthy Adults
Optimizing Heart Failure and Chronic Kidney Disease Treatment in Elderly Patients Using Sodium Zirconium Cyclosilicate to Manage Potassium Levels
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Convergent Hybrid Ablation Versus Catheter Ablation in Patients With Persistent Atrial Fibrillation and Heart Failure: HALT AF Study Protocol and Rationale for a Multicenter Randomized Controlled Trial.